BiotechTube
Home/Reprieve Cardiovascular/Andrew Halpert
AH

Andrew Halpert

Vice President of R&D

Reprieve Cardiovascular

Therapeutic Areas

Cardiovascular

Reprieve Cardiovascular Pipeline

DrugIndicationPhase
Reprieve SystemFluid overload in Acute Decompensated Heart Failure (ADHF)Pilot Study

Leadership Team at Reprieve Cardiovascular

MP
Mark Pacyna
Chief Executive Officer
TF
Tony Fields
Chief Operating Officer
AB
Adam Bartnik
Chief Financial Officer
AF
Annemarie Forrest
Vice President of Clinical Affairs
DJ
Dr. Javed Butler
Scientific Advisory Board
View full Reprieve Cardiovascular profile